These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6191619)

  • 1. Decrease in natural killer cell activity in kidney allograft recipients.
    Moreau JF; Soulillou JP; Ythier A; Hegaret A; Fauconnier B
    Ann Immunol (Paris); 1983; 134C(2):191-205. PubMed ID: 6191619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
    Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
    Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy.
    Lipinski M; Tursz T; Kreis H; Finale Y; Amiel JL
    Transplantation; 1980 Mar; 29(3):214-8. PubMed ID: 6987785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon alpha on natural killer cell cytotoxicity in kidney transplant recipients.
    Kelly AP; Schooley RT; Rubin RH; Hirsch MS
    Clin Immunol Immunopathol; 1984 Jul; 32(1):20-8. PubMed ID: 6329567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of St. John's Wort (Hypericum perforatum) on NK cell activity in vitro.
    Helgason CM; Frank JL; Johnson DR; Frank MG; Hendricks SE
    Immunopharmacology; 2000 Mar; 46(3):247-51. PubMed ID: 10741904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous serum collected 1 h post-exercise enhances natural killer cell cytotoxicity.
    Gupta P; Bigley AB; Markofski M; Laughlin M; LaVoy EC
    Brain Behav Immun; 2018 Jul; 71():81-92. PubMed ID: 29656052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient natural killer function in patients receiving immunosuppressive drugs: analysis at the cellular level.
    Dupont E; Vandercruys M; Wybran J
    Cell Immunol; 1984 Oct; 88(1):85-95. PubMed ID: 6236888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of protein tyrosine kinase: a possible requirement for fixed-bacteria and lipopolysaccharide-induced increase in human natural killer cell activity.
    Puente J; Salas MA; Canon C; Miranda D; Wolf ME; Mosnaim AD
    Int J Clin Pharmacol Ther; 1996 May; 34(5):212-8. PubMed ID: 8738858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.
    Guillou PJ; Giles GR; Ramsden CW
    J Clin Immunol; 1986 Sep; 6(5):373-80. PubMed ID: 3533973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of natural killer cell activity with serum IgE.
    Kusaka Y; Sato K; Zhang Q; Morita A; Kasahara T; Yanagihara Y
    Int Arch Allergy Immunol; 1997 Apr; 112(4):331-5. PubMed ID: 9104787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of serotonin on the cytotoxic activity of natural killer lymphocytes in patients with the first episode of endogenous psychosis].
    Vasil'eva EF; Koliaskina GI; Brusov OS; Faktor MI; Kaleda VG; Barkhatova NA; Bogdanova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):61-6. PubMed ID: 21512504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of natural killer cell activity by retroplacental sera as compared to peripheral sera. Lack of influence of immune complexes.
    Struyf NJ; De Cleyn KM; Bridts CH; De Clerck LS; Buytaert PM; Stevens WJ
    J Reprod Immunol; 1989 Dec; 16(3):261-7. PubMed ID: 2614760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.